Vault-13

Avidity Partners Management LP

DALLAS, TX · CIK 1791827 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2020 · limited partnership

As an employer

Where they work

people there (dot area)number not reportedmain officeHover or tap a dot. Australian and UK companies are placed at their business or registered address, with their staff across the whole country.

Offices

From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.

CityCountryPeople
Dallas, TX (main office)United States United Statesabout 5
New York, NYUnited States United States2

Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.

$4.4bn reported value -3.3% vs Q1 2022
82positions
45.0%in top 10
10 new 31 added 13 reduced 19 sold out vs Q1 2022

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 3,499,000 $231.2m5.31% 5.31% ReducedShares held: Q3 2021 1.4m, Q4 2021 2.9m, Q1 2022 3.7m, Q2 2022 3.5m -201.0k -201,000 -5.4%
2 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 793,000 $223.5m5.13% 5.13% AddedShares held: Q3 2021 926.4k, Q4 2021 280.0k, Q1 2022 545.6k, Q2 2022 793.0k +247.4k +247,400 45.3%
3 ARGENX SE SPONSORED ADR ARGX ARGX 572,500 $216.9m4.98% 4.98% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 176.0k, Q2 2022 572.5k +396.5k +396,500 225.3%
4 ELEVANCE HEALTH INC COM ELV ELV 441,000 $212.8m4.89% 4.89% AddedShares held: Q3 2021 0, Q4 2021 321.0k, Q1 2022 399.4k, Q2 2022 441.0k +41.6k +41,600 10.4%
5 AVANTOR INC COM AVTR AVTR 6,652,700 $206.9m4.75% 4.75% AddedShares held: Q3 2021 3.2m, Q4 2021 4.8m, Q1 2022 5.7m, Q2 2022 6.7m +984.4k +984,400 17.4%
6 ELI LILLY & CO COM LLY LLY 610,000 $197.8m4.54% 4.54% NewShares held: Q3 2021 330.0k, Q4 2021 344.8k, Q1 2022 0, Q2 2022 610.0k
7 HUMANA INC COM HUM HUM 412,300 $193.0m4.43% 4.43% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 198.9k, Q2 2022 412.3k +213.4k +213,400 107.3%
8 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 725,600 $171.0m3.93% 3.93% AddedShares held: Q3 2021 351.0k, Q4 2021 535.0k, Q1 2022 718.9k, Q2 2022 725.6k +6.7k +6,654 0.9%
9 JOHNSON & JOHNSON COM JNJ JNJ 900,200 $159.8m3.67% 3.67% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 354.0k, Q2 2022 900.2k +546.2k +546,200 154.3%
10 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 1,856,900 $148.1m3.40% 3.40% AddedShares held: Q3 2021 826.0k, Q4 2021 1.0m, Q1 2022 1.1m, Q2 2022 1.9m +725.5k +725,500 64.1%
11 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 1,467,600 $143.1m3.28% 3.28% AddedShares held: Q3 2021 848.9k, Q4 2021 1.3m, Q1 2022 1.2m, Q2 2022 1.5m +307.6k +307,600 26.5%
12 ARVINAS INC COM ARVN ARVN 3,355,623 $141.2m3.24% 3.24% AddedShares held: Q3 2021 2.2m, Q4 2021 2.5m, Q1 2022 2.9m, Q2 2022 3.4m +440.3k +440,323 15.1%
13 SPDR SER TR S&P BIOTECH XBI XBI 1,875,000 $139.3m3.20% 3.20% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 440.0k, Q2 2022 1.9m +1.4m +1,435,000 326.1%
14 MCKESSON CORP COM MCK MCK 388,800 $126.8m2.91% 2.91% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 189.5k, Q2 2022 388.8k +199.3k +199,300 105.2%
15 UNITEDHEALTH GROUP INC COM UNH UNH 242,200 $124.4m2.86% 2.86% ReducedShares held: Q3 2021 0, Q4 2021 123.1k, Q1 2022 259.6k, Q2 2022 242.2k -17.4k -17,400 -6.7%
16 ABBVIE INC COM ABBV ABBV 755,000 $115.6m2.65% 2.65% ReducedShares held: Q3 2021 1.6m, Q4 2021 2.0m, Q1 2022 1.5m, Q2 2022 755.0k -711.1k -711,100 -48.5%
17 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 5,450,000 $104.9m2.41% 2.41% AddedShares held: Q3 2021 4.8m, Q4 2021 4.8m, Q1 2022 4.8m, Q2 2022 5.5m +626.6k +626,600 13.0%
18 CATALENT INC COM CTLT CTLT 955,000 $102.5m2.35% 2.35% AddedShares held: Q3 2021 398.0k, Q4 2021 695.0k, Q1 2022 782.0k, Q2 2022 955.0k +173.0k +173,000 22.1%
19 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 3,585,881 $100.8m2.31% 2.31% AddedShares held: Q3 2021 2.5m, Q4 2021 2.7m, Q1 2022 3.2m, Q2 2022 3.6m +408.9k +408,882 12.9%
20 SEAGEN INC COM SGEN SGEN 550,000 $97.3m2.23% 2.23% AddedShares held: Q3 2021 537.0k, Q4 2021 685.0k, Q1 2022 100.0k, Q2 2022 550.0k +450.0k +450,000 450.0%
21 BOSTON SCIENTIFIC CORP COM BSX BSX 2,525,000 $94.1m2.16% 2.16% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.2m, Q2 2022 2.5m +1.3m +1,328,900 111.1%
22 BIOGEN INC COM BIIB BIIB 440,566 $89.8m2.06% 2.06% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 365.0k, Q2 2022 440.6k +75.6k +75,566 20.7%
23 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 1,479,500 $88.3m2.03% 2.03% AddedShares held: Q3 2021 455.0k, Q4 2021 700.0k, Q1 2022 869.0k, Q2 2022 1.5m +610.5k +610,500 70.2%
24 ACADIA HEALTHCARE COMPANY IN COM ACHC ACHC 1,035,000 $70.0m1.61% 1.61% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.0m
25 INTELLIA THERAPEUTICS INC COM NTLA NTLA 1,125,194 $58.2m1.34% 1.34% AddedShares held: Q3 2021 251.0k, Q4 2021 0, Q1 2022 390.1k, Q2 2022 1.1m +735.1k +735,119 188.5%
26 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 1,000,000 $55.0m1.26% 1.26% ReducedShares held: Q3 2021 894.0k, Q4 2021 711.9k, Q1 2022 1.1m, Q2 2022 1.0m -95.0k -95,000 -8.7%
27 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 1,438,999 $50.7m1.16% 1.16% AddedShares held: Q3 2021 673.7k, Q4 2021 875.0k, Q1 2022 955.0k, Q2 2022 1.4m +484.0k +483,999 50.7%
28 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 1,350,000 $50.4m1.16% 1.16% ReducedShares held: Q3 2021 1.1m, Q4 2021 1.2m, Q1 2022 1.4m, Q2 2022 1.4m -13.8k -13,800 -1.0%
29 NATERA INC COM NTRA NTRA 1,369,100 $48.5m1.11% 1.11% AddedShares held: Q3 2021 638.7k, Q4 2021 940.0k, Q1 2022 1.3m, Q2 2022 1.4m +69.1k +69,100 5.3%
30 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 775,504 $44.3m1.02% 1.02% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 775.5k
31 IDEAYA BIOSCIENCES INC COM IDYA IDYA 2,972,947 $41.0m0.94% 0.94% AddedShares held: Q3 2021 2.4m, Q4 2021 2.6m, Q1 2022 2.7m, Q2 2022 3.0m +282.9k +282,947 10.5%
32 BELLUS HEALTH INC NEW COM NEW BLU BLU 4,265,000 $39.4m0.90% 0.90% AddedShares held: Q3 2021 4.9m, Q4 2021 3.8m, Q1 2022 3.7m, Q2 2022 4.3m +580.0k +580,000 15.7%
33 ALTIMMUNE INC COM NEW ALT ALT 2,981,000 $34.9m0.80% 0.80% AddedShares held: Q3 2021 2.2m, Q4 2021 2.8m, Q1 2022 2.9m, Q2 2022 3.0m +116.0k +116,000 4.0%
34 KEZAR LIFE SCIENCES INC COM COM 4,050,000 $33.5m0.77% 0.77% AddedShares held: Q3 2021 260.0k, Q4 2021 3.2m, Q1 2022 3.5m, Q2 2022 4.0m +532.0k +532,000 15.1%
35 AVIDITY BIOSCIENCES INC COM RNA RNA 2,080,200 $30.2m0.69% 0.69% AddedShares held: Q3 2021 1.6m, Q4 2021 1.8m, Q1 2022 2.0m, Q2 2022 2.1m +35.2k +35,200 1.7%
36 KARUNA THERAPEUTICS INC COM COM 204,570 $25.9m0.59% 0.59% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 204.6k
37 REVOLUTION MEDICINES INC COM RVMD RVMD 1,325,000 $25.8m0.59% 0.59% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.3m
38 ARK ETF TR GENOMIC REV ETF ARKG ARKG 750,000 $23.6m0.54% 0.54% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 750.0k
39 VIR BIOTECHNOLOGY INC COM VIR VIR 758,211 $19.3m0.44% 0.44% ReducedShares held: Q3 2021 515.0k, Q4 2021 700.0k, Q1 2022 780.0k, Q2 2022 758.2k -21.8k -21,789 -2.8%
40 NKARTA INC COM NKTX NKTX 1,414,082 $17.4m0.40% 0.40% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.4m
41 PHATHOM PHARMACEUTICALS INC COM PHAT PHAT 1,919,800 $16.2m0.37% 0.37% ReducedShares held: Q3 2021 0, Q4 2021 1.9m, Q1 2022 1.9m, Q2 2022 1.9m -26.2k -26,200 -1.4%
42 CARIBOU BIOSCIENCES INC COM CRBU CRBU 2,950,000 $16.0m0.37% 0.37% AddedShares held: Q3 2021 2.5m, Q4 2021 2.7m, Q1 2022 2.8m, Q2 2022 3.0m +130.9k +130,933 4.6%
43 DECIPHERA PHARMACEUTICALS IN COM DCPH DCPH 1,200,000 $15.8m0.36% 0.36% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.2m
44 NUVATION BIO INC COM CL A NUVB NUVB 4,855,000 $15.7m0.36% 0.36% ReducedShares held: Q3 2021 7.3m, Q4 2021 7.4m, Q1 2022 4.9m, Q2 2022 4.9m -6 -6 0.0%
45 IOVANCE BIOTHERAPEUTICS INC COM IOVA IOVA 1,392,300 $15.4m0.35% 0.35% ReducedShares held: Q3 2021 1.5m, Q4 2021 3.8m, Q1 2022 6.0m, Q2 2022 1.4m -4.7m -4,650,919 -77.0%
46 XENON PHARMACEUTICALS INC COM XENE XENE 450,000 $13.7m0.31% 0.31% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 450.0k
47 SI-BONE INC COM SIBN SIBN 1,000,000 $13.2m0.30% 0.30% UnchangedShares held: Q3 2021 831.2k, Q4 2021 987.4k, Q1 2022 1.0m, Q2 2022 1.0m
48 SEASPINE HLDGS CORP COM SPNE SPNE 2,010,000 $11.4m0.26% 0.26% UnchangedShares held: Q3 2021 1.9m, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 2.0m
49 ALPHATEC HLDGS INC COM NEW ATEC ATEC 1,715,000 $11.2m0.26% 0.26% ReducedShares held: Q3 2021 2.8m, Q4 2021 2.8m, Q1 2022 2.7m, Q2 2022 1.7m -1.0m -1,020,600 -37.3%
50 APELLIS PHARMACEUTICALS INC COM APLS APLS 215,000 $9.7m0.22% 0.22% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 210.0k, Q2 2022 215.0k +5.0k +5,000 2.4%
51 JAZZ PHARMACEUTICALS PLC SHS USD JAZZ JAZZ 62,000 $9.7m0.22% 0.22% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 62.0k
52 ALPINE IMMUNE SCIENCES INC COM NVLS NVLS 998,565 $8.5m0.20% 0.20% ReducedShares held: Q3 2021 1.9m, Q4 2021 1.3m, Q1 2022 1.2m, Q2 2022 998.6k -208.4k -208,435 -17.3%
53 ESSA PHARMA INC COM NEW EPI EPI 2,460,000 $7.7m0.18% 0.18% UnchangedShares held: Q3 2021 2.5m, Q4 2021 2.5m, Q1 2022 2.5m, Q2 2022 2.5m
54 CENTURY THERAPEUTICS INC COM IPSC IPSC 865,000 $7.3m0.17% 0.17% UnchangedShares held: Q3 2021 739.3k, Q4 2021 851.5k, Q1 2022 865.0k, Q2 2022 865.0k
55 ERASCA INC COM ERAS ERAS 995,000 $5.5m0.13% 0.13% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 995.0k, Q2 2022 995.0k
56 CYTEIR THERAPEUTICS INC COM COM 1,850,000 $5.5m0.13% 0.13% UnchangedShares held: Q3 2021 1.7m, Q4 2021 1.8m, Q1 2022 1.9m, Q2 2022 1.9m
57 AN2 THERAPEUTICS INC COM ANTX ANTX 688,330 $5.3m0.12% 0.12% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 688.3k, Q2 2022 688.3k
58 COMPASS THERAPEUTICS INC COM CMPX CMPX 2,000,000 $5.3m0.12% 0.12% UnchangedShares held: Q3 2021 0, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 2.0m
59 MEDICUS SCIENCES ACQUISITION CL A SHS CL A SHS 520,000 $5.1m0.12% 0.12% UnchangedShares held: Q3 2021 520.0k, Q4 2021 520.0k, Q1 2022 520.0k, Q2 2022 520.0k
60 BCLS ACQUISITION CORP COM CL A COM CL A 500,000 $5.0m0.11% 0.11% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
61 ARYA SCIENCES ACQU CORP IV CL A CL A 500,000 $4.9m0.11% 0.11% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
62 PANACEA ACQUISITION CORP II CL A SHS CL A SHS 500,000 $4.9m0.11% 0.11% UnchangedShares held: Q3 2021 500.0k, Q4 2021 500.0k, Q1 2022 500.0k, Q2 2022 500.0k
63 SENTINELONE INC CL A S S 204,500 $4.8m0.11% 0.11% UnchangedShares held: Q3 2021 200.0k, Q4 2021 208.0k, Q1 2022 204.5k, Q2 2022 204.5k
64 IVERIC BIO INC COM OPHT OPHT 430,117 $4.1m0.09% 0.09% ReducedShares held: Q3 2021 4.1m, Q4 2021 7.0m, Q1 2022 6.5m, Q2 2022 430.1k -6.0m -6,045,283 -93.4%
65 HEALTH SCIENCES ACQ CORP 2 ORD SHS OBIO OBIO 400,000 $4.0m0.09% 0.09% UnchangedShares held: Q3 2021 400.0k, Q4 2021 400.0k, Q1 2022 400.0k, Q2 2022 400.0k
66 TANGO THERAPEUTICS INC COM TNGX TNGX 813,640 $3.7m0.08% 0.08% AddedShares held: Q3 2021 300.0k, Q4 2021 705.0k, Q1 2022 721.0k, Q2 2022 813.6k +92.6k +92,640 12.8%
67 HYPERFINE INC COM CL A HYPR HYPR 1,503,754 $3.4m0.08% 0.08% UnchangedShares held: Q3 2021 0, Q4 2021 1.5m, Q1 2022 1.5m, Q2 2022 1.5m
68 CAREMAX INC COM CL A COM CL A 755,329 $2.7m0.06% 0.06% UnchangedShares held: Q3 2021 827.4k, Q4 2021 827.4k, Q1 2022 755.3k, Q2 2022 755.3k
69 PHASEBIO PHARMACEUTICALS INC COM PHAS PHAS 4,405,000 $2.6m0.06% 0.06% UnchangedShares held: Q3 2021 4.4m, Q4 2021 4.4m, Q1 2022 4.4m, Q2 2022 4.4m
70 FIELD TRIP HEALTH LTD COM COM 2,976,000 $2.5m0.06% 0.06% UnchangedShares held: Q3 2021 3.6m, Q4 2021 3.2m, Q1 2022 3.0m, Q2 2022 3.0m
71 ONCOSEC MED INC COM COM 2,945,000 $2.2m0.05% 0.05% UnchangedShares held: Q3 2021 2.9m, Q4 2021 2.9m, Q1 2022 2.9m, Q2 2022 2.9m
72 OTONOMY INC COM OTIC OTIC 1,000,000 $2.1m0.05% 0.05% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 1.3m, Q2 2022 1.0m -349.9k -349,905 -25.9%
73 SOCIAL CAP SUVRETTA HLD CRPI CLASS A ORD SHS CLASS A ORD SHS 200,000 $2.0m0.05% 0.05% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
74 SOCIAL CAP SUVRETTA HLDS CRP CLASS A ORD SHS CLASS A ORD SHS 200,000 $2.0m0.05% 0.05% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
75 GRAPHITE BIO INC COM GRPH GRPH 710,000 $2.0m0.04% 0.04% UnchangedShares held: Q3 2021 749.0k, Q4 2021 710.0k, Q1 2022 710.0k, Q2 2022 710.0k
76 SOCIAL CAP SUVRETTA HLDS CRP CLASS A ORD SHS CLASS A ORD SHS 200,000 $1.9m0.04% 0.04% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
77 SOCIAL CAP SUVRETTA HLDS CP CLASS A ORD SHS CLASS A ORD SHS 200,000 $1.9m0.04% 0.04% UnchangedShares held: Q3 2021 200.0k, Q4 2021 200.0k, Q1 2022 200.0k, Q2 2022 200.0k
78 SCYNEXIS INC COM NEW COM NEW 959,524 $1.8m0.04% 0.04% AddedShares held: Q3 2021 2.1m, Q4 2021 2.2m, Q1 2022 544.0k, Q2 2022 959.5k +415.5k +415,481 76.4%
79 SEMA4 HOLDINGS CORP COM CL A SMFR SMFR 950,000 $1.2m0.03% 0.03% UnchangedShares held: Q3 2021 1.7m, Q4 2021 950.0k, Q1 2022 950.0k, Q2 2022 950.0k
80 SCIENCE 37 HOLDINGS INC COM COM 430,000 $864.0k0.02% 0.02% UnchangedShares held: Q3 2021 0, Q4 2021 394.0k, Q1 2022 430.0k, Q2 2022 430.0k
81 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 99,999 $28.0k0.00% 0.00% UnchangedShares held: Q3 2021 100.0k, Q4 2021 100.0k, Q1 2022 100.0k, Q2 2022 100.0k
82 MEDICUS SCIENCES ACQUISITION *W EXP 02/12/202 *W EXP 02/12/202 57,770 $10.0k0.00% 0.00% UnchangedShares held: Q3 2021 57.8k, Q4 2021 57.8k, Q1 2022 57.8k, Q2 2022 57.8k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
MERCK & CO INC MRK MRK 2,370,000 $194.5m2.4m shares
BAXTER INTL INC BAX BAX 1,915,500 $148.5m1.9m shares
BIOHAVEN PHARMACTL HLDG CO L BHVN BHVN 1,231,000 $146.0m1.2m shares
MIRATI THERAPEUTICS INC MRTX MRTX 1,393,000 $114.5m1.4m shares
INTUITIVE SURGICAL INC ISRG ISRG 325,000 $98.0m325.0k shares
ADICET BIO INC 3,120,000 $62.3m3.1m shares
EDWARDS LIFESCIENCES CORP EW EW 440,000 $51.8m440.0k shares
BAUSCH HEALTH COS INC BHC BHC 1,694,700 $38.7m1.7m shares
INSMED INC INSM INSM 1,354,539 $31.8m1.4m shares
CHEMOCENTRYX INC CCXI CCXI 1,175,000 $29.5m1.2m shares
AXSOME THERAPEUTICS INC AXSM AXSM 711,000 $29.4m711.0k shares
ARCUS BIOSCIENCES INC RCUS RCUS 912,000 $28.8m912.0k shares
PENUMBRA INC PEN PEN 104,000 $23.1m104.0k shares
VIRIDIAN THERAPEUTICS INC VRDN VRDN 1,040,000 $19.2m1.0m shares
BLUEPRINT MEDICINES CORP BPMC BPMC 291,184 $18.6m291.2k shares
GALAPAGOS NV LKFT LKFT 215,000 $13.3m215.0k shares
DYNAMICS SPECIAL PURPOSE COR 500,000 $4.9m500.0k shares
HELIX ACQUISITION CORP MLTX MLTX 400,000 $4.4m400.0k shares
GRITSTONE BIO INC GRTS GRTS 560,000 $2.3m560.0k shares

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
IMMUNIC INC 13G · filed 2026-04-17 9.9% +5.1 pts 13G 2026-04-17
CONTEXT THERAPEUTICS INC CNTX · 13G · filed 2026-05-12 CNTX 8.7%≈ $4.6m -1.2 pts 13G 2026-05-12
PERSPECTIVE THERAPEUTICS INC CATX · 13G · filed 2026-03-10 CATX 5.3%≈ $20.6m +1.1 pts 13G 2026-03-10